Skip to content

Nabiximols

NERVOUS SYSTEM

Also known as: cannabinoids, GW-1000, nabidiolex, sativex, tetranabinex

ATC N02BG10

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Nabiximols is a drug catalogued in DrugCentral. Recorded indications include Muscle Spasticity due to Multiple Sclerosis.

  • Indications: Muscle Spasticity due to Multiple Sclerosis.
  • ATC code: N02BG10 (Other analgesics and antipyretics).
  • Molecular formula: C42H60O4; molecular weight 628.94 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Muscle Spasticity due to Multiple Sclerosis

ATC classification

ATC codeTherapeutic hierarchy
N02BG10NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Other analgesics and antipyretics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
COVID-19185.6
Multiple sclerosis relapse167.5
Lymphopenia66.2
Urinary tract infection57.6
Cystitis noninfective55.6
Muscle spasticity52.3
Multiple sclerosis46.3
SARS-CoV-2 antibody test negative46.0
Progressive multifocal leukoencephalopathy29.7
Sensory disturbance28.9
Vitamin D decreased28.8

Chemical structure

Molecular formulaC42H60O4
Molecular weight628.94 g/mol
CAS number56575-23-6
InChIKey—
PubChem CID9852188

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Nabiximols used for?

DrugCentral lists the following indications for Nabiximols: Muscle Spasticity due to Multiple Sclerosis.

What is the chemical formula of Nabiximols?

Nabiximols has the molecular formula C42H60O4 and a molecular weight of 628.94 g/mol.

Browse: all drugs starting with N · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications1
FormulaC42H60O4
DrugCentral ID4793
Interactive profile